Follow Us: social media social media social media    Language :          

Reaksi Drug Safety News 2017 - Issue 6/2017

Reaksi Drug Safety News 2017,

Issue 6/2017

 

  • Ketamine: Risk of Severe Liver Damage with Repeated and/or Prolonged Use at High Doses
  • Recombinant Human Erythropoietins: Risk of Severe Cutaneous Adverse Reactions (SCARs)

 



 
 
  DOWNLOAD PDF


 

 

 


  Reaksi Archive

qrcode